Bridge to the Future 2015
HudsonAlpha’s Bridge to the Future Campaign supports the Institute’s largest and most exciting phase of growth since opening its doors in 2008. HudsonAlpha has launched a campaign to raise $7 million to support the HudsonAlpha Clinic for Genomic Medicine and we need your help to reach this goal.
The Center for Personal Genomics is being led by Howard Jacob, Ph.D., Executive Vice President for Medical Genomics and Chief Medical Genomics Officer. Jacob’s recruitment also includes four of his colleagues from the Medical College of Wisconsin.
It is hard to overstate the significance of this team’s recruitment to HudsonAlpha. Working together, this team was the first in the world to use genomic sequencing to save the life of a child. Efforts to diagnose the child’s life-threatening disorder based on his symptoms had failed. Using genomic analysis, they identified a single gene mutation that let to the disease diagnosis and successful course of treatment. The team went on to contribute to the diagnosis of several other genetic diseases by sequencing the genomic of more than 500 children. This encouraging experience fueled Jacob and his colleagues to build a first-of-its-kind clinical program for children and adults that uses genomic sequencing to guide patient care. This team is bringing that program to HudsonAlpha, and we are calling it the Center for Personal Genomics.
Initially, the Center for Personal Genomics will provide whole genome sequencing, analysis and interpretation for children and adults with rare and undiagnosed disorders to identify diagnoses and possible treatment options.
By using the advanced technology in HudsonAlpha’s Genomic Services Lab, This team will be able to sequence the genomes of more than 5,000 patients a year from all over the U.S. and throughout the world. This is significantly more than has ever been done by one institution thus far.
As research discoveries continue to advance the field of medical genomics, the Center for Personal Genomics will offer whole genome sequencing for diagnosis and treatment of many other diseases including multiple types of cancer, neurological and psychiatric disorders, and immune response disorders. The Center will harness the technology and expertise within the Institute to deliver better treatments and more preventative medicines for patients.
Without philanthropy, HudsonAlpha would not exist. From the original gifts that made HudsonAlpha possible to the extraordinary support from the State of Alabama and from our community, philanthropy has been vital to our existence. We are in awe of the Institute’s progress in the last six years. But we have the potential to do so much more. The problems we address are shared by all humanity. It is not an exaggeration to say that HudsonAlpha can create a better world. Please help insure our vitality, growth and success for years to come.
For more information on supporting our Bridge to the Future, contact Lynne Berry at email@example.com.
The HudsonAlpha Foundation, a 501(c)(3) nonprofit organization, is the supporting entity for the HudsonAlpha Institute for Biotechnology. Tax-deductible contributions to the foundation are for the sole purpose of advancing the mission of the HudsonAlpha Institute for Biotechnology.
Tax identification #27-2320591